Results from our recent poll indicate that many ophthalmologists (63%) plan to use biosimilars in their clinical practice.
Ophthalmology Times® polled our audience with the following question from September 26, 2022 to October 10, 2022: Will you use biosimilars in your ophthalmic practice?
The poll appeared on OphthalmologyTimes.com and was promoted in our e-newsletters during this time. Results show a majority of ophthalmologists plan to use biosimilars in their practice.
37 responses were recorded, in total. Of these:
23% responded, "Yes, I plan to use biosimilars in my practice."
14% responded, "No, I do not plan to use biosimilars in my practice."